Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: SCHEDULE 14C

Oct 23, 2020 04:09PM

Oct 23, 2020 04:26PM

ya

at the close of business on October 27, 2020 (the “Record Date”)

 

in connection with the approval of the following actions taken by the Company’s Board of Directors (the “Board”) on October 21, 2020 and by written consent of the holders of a majority of the voting power of the issued and outstanding capital stock of the Company on October 22, 2020:

 

#3

To effect a reverse stock split of all of the Company’s outstanding shares of Common Stock by a ratio of 1-for-500 (the “Reverse Stock Split”);

basically 50,000 shares is 100 shares

and

.01 is $5.00

 

hum

Share
New Message
Please login to post a reply